OBIPHAR
The computed 12-month bankruptcy probability of OBIPHAR is 0.6% (low). The company has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 20 yrs |
| Locations | 1 |
| Publications | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | micro | 14-07-2025 | 2025-00271089 |
| 31-12-2023 | micro | 06-08-2024 | 2024-00331633 |
| 31-12-2022 | micro | 23-08-2023 | 2023-00345494 |
| 31-12-2021 | micro | 16-08-2022 | 2022-20289639 |
| 31-12-2020 | volledig | 09-08-2021 | 2021-47200421 |
| 31-12-2019 | volledig | 25-08-2020 | 2020-45100511 |
| 31-12-2018 | volledig | 07-08-2019 | 2019-44500395 |
| 31-12-2017 | volledig | 02-08-2018 | 2018-42500491 |
| 31-12-2016 | volledig | 04-07-2017 | 2017-27000121 |
| 31-12-2015 | volledig | 19-07-2016 | 2016-33500208 |
| NACE primary | Retail trade(47730) |
| Legal form | Public limited company(014) |
| Incorporation | 22-12-2005 |
| Status | Active |
| Postal code | 7080 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 53028A0282/00E003 | Wallonia | 7,354 m² | 1 · 5,065 m² | 6.3 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
25-11-2024 2 reappointed
- SA GESTIPHARMA, Commissaris
- SA FINPHARMA, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": null,
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": null,
"name": "SA GESTIPHARMA",
"address": null,
"country": null,
"legal_form": "SA"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": null,
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": null,
"name": "SA FINPHARMA",
"address": null,
"country": null,
"legal_form": "SA"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": null,
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Cette AGO du 28 juin 2024 donne \u00E9galement d\u00E9charge pour la p\u00E9riode entre l\u0027AGE du 27/11/2023 pass\u00E9e devant notaire \u00E0 l\u0027occasion de modification statutaire et cette pr\u00E9sente AGO du 28 juin 2024.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Frameries",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-11-25",
"filing_date": "2024-11-13",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2024-06-28",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0878.100.418",
"name_full": "OBIPHAR",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | OBIPHAR |